Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ifetroban in Symptomatic AERD
NCT03028350Phase 2Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Jul 2017
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ifetroban in Aspirin Exacerbated Respiratory Disease (AERD), sponsored by Cumberland Pharmaceuticals. Started Jul 2017; status: completed.
02
Drugs
ifetroban
03
Conditions
Aspirin Exacerbated Respiratory Disease (AERD)
Beyond the preview
Go deeper on NCT03028350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028350.